Literature DB >> 26843539

Trends in 'poor responder' research: lessons learned from RCTs in assisted conception.

Athanasios Papathanasiou1, Belinda J Searle, Nicole M A King2, Siladitya Bhattacharya2.   

Abstract

BACKGROUND: A substantial minority of women undergoing IVF will under-respond to controlled ovarian hyperstimulation. These women-so-called 'poor responders'-suffer persistently reduced success rates after IVF. Currently, no single intervention is unanimously accepted as beneficial in overcoming poor ovarian response (POR). This has been supported by the available research on POR, which consists mainly of randomized controlled trials (RCTs ) with an inherent high-risk of bias. The aim of this review was to critically appraise the available experimental trials on POR and provide guidance towards more useful-less wasteful-future research.
METHODS: A comprehensive review was undertaken of RCTs on 'poor responders' published in the last 15 years. Data on various methodological traits as well as important clinical characteristics were extracted from the included studies and summarized, with a view to identifying deficiencies from which lessons can be learned. Based on this analysis, recommendations were provided for further research in this field of assisted conception.
RESULTS: We selected and analysed 75 RCTs. A valid, 'low-risk' randomization method was reported in three out of four RCTs. An improving trend in reporting concealment of patient allocation was also evident over the 15-year period. In contrast, <1 in 10 RCTs 'blinded' patients and <1 in 5 RCTs 'blinded' staff to the proposed intervention. Only 1 in 10 RCTs 'blinded' ultrasound practitioners to patient allocation, when assessing the outcome of early pregnancy. The majority of trials reported an intention-to-treat analysis for at least one of their outcomes, with an improving trend in the recent years. Substantial variation was noted in the definitions used for 'poor responders', the most popular being 'low ovarian response at previous stimulation'. The preferred cut-off value for defining previous low response has been 'less or equal to three retrieved oocytes'. The most popular tests used for diagnosing diminished ovarian reserve have been antral follicle count and FSH. Although the Bologna criteria for POR were only recently introduced, they are expected to become a popular definition in future 'poor responder' trials. Numerous interventions have been studied on 'poor responders'. Most of these have been applied before/during controlled ovarian hyperstimulation. The antagonist protocol, the microdose flare protocol and the long down-regulation protocol have been among the most popular interventions. The analysis of outcomes revealed a clear improving trend in reporting live birth. In contrast, only 10% of RCTs reported significant improvement in reproductive outcomes among tested interventions. Twelve 'significant' interventions were reported, each supported by a single 'positive' RCT. Finally, trials of higher methodological quality were more likely to have been published in a high-impact journal.
CONCLUSIONS: Overall, the majority of published trials on POR suffer from methodological flaws and are, thus, regarded as being high-risk for bias. The same trials have used a variety of definitions for their poor responders and a variety of interventions for their head-to-head comparisons. Not surprisingly, discrepancies are also evident in the findings of trials comparing similar interventions. Based on the identified deficiencies, this novel type of 'methodology and clinical' review has introduced custom recommendations on how to improve future experimental research in the 'poor responder' population.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IVF; RCT; blinding; live birth; low responder; low response; methodology; ovarian stimulation; poor responder; review

Mesh:

Year:  2016        PMID: 26843539     DOI: 10.1093/humupd/dmw001

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  26 in total

1.  Effect of follicular flushing on reproductive outcomes in patients with poor ovarian response undergoing assisted reproductive technology.

Authors:  Anna L M Souza; Marcos Sampaio; Graciele B Noronha; Ludiana G R Coster; Roberta S G de Oliveira; Selmo Geber
Journal:  J Assist Reprod Genet       Date:  2017-07-21       Impact factor: 3.412

Review 2.  Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.

Authors:  Shuang Yang; Nenghui Liu; Yanping Li; Lei Zhang; Rongya Yue
Journal:  Arch Gynecol Obstet       Date:  2020-11-24       Impact factor: 2.344

Review 3.  Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.

Authors:  Marco Noventa; Amerigo Vitagliano; Alessandra Andrisani; Mija Blaganje; Paola Viganò; Enrico Papaelo; Marco Scioscia; Francesco Cavallin; Guido Ambrosini; Mauro Cozzolino
Journal:  J Assist Reprod Genet       Date:  2019-01-05       Impact factor: 3.412

4.  Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort study.

Authors:  Mauro Cozzolino; Gustavo Nardini Cecchino; Ernesto Bosch; Juan Antonio Garcia-Velasco; Nicolás Garrido
Journal:  J Assist Reprod Genet       Date:  2021-04-13       Impact factor: 3.357

Review 5.  Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel's back.

Authors:  Sabahat Rasool; Duru Shah
Journal:  Fertil Res Pract       Date:  2017-10-11

6.  Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.

Authors:  Daniele Santi; Livio Casarini; Carlo Alviggi; Manuela Simoni
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-01       Impact factor: 5.555

7.  The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.

Authors:  Xue-Li Li; Li Wang; Fang Lv; Xia-Man Huang; Li-Ping Wang; Yu Pan; Xiao-Mei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.

Authors:  Peter Humaidan; Carlo Alviggi; Robert Fischer; Sandro C Esteves
Journal:  F1000Res       Date:  2016-12-23

9.  Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.

Authors:  Abbas Aflatoonian; Marzieh Lotfi; Lida Saeed; Nasim Tabibnejad
Journal:  Reprod Sci       Date:  2021-03-08       Impact factor: 3.060

10.  Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.

Authors:  Yangying Xu; Victoria Nisenblat; Cuiling Lu; Rong Li; Jie Qiao; Xiumei Zhen; Shuyu Wang
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.